Rescue Inhaler Use for Acute Asthma and COPD Symptoms
For acute asthma symptoms or COPD exacerbations, use a short-acting beta-2 agonist (SABA) such as albuterol 2-4 puffs (180-360 mcg) via metered-dose inhaler (MDI) with spacer, or 2.5-5 mg via nebulizer, repeated every 20 minutes for up to 3 doses initially, then every 1-4 hours as needed based on symptom severity. 1
Initial Dosing Strategy
Mild-to-Moderate Exacerbations
- Albuterol MDI with spacer: 4-8 puffs (360-720 mcg) every 20 minutes for 3 doses 1
- MDI with spacer is equally effective as nebulizer therapy when used with proper technique 1
- After initial 3 doses, continue every 1-4 hours as needed based on response 1
Severe Exacerbations (Asthma)
Severity indicators: Cannot complete sentences, respiratory rate >25/min, heart rate >110/min, peak flow <50% predicted 1
- Nebulized albuterol 5 mg (or terbutaline 10 mg) every 20 minutes for 3 doses 1
- If inadequate response after initial doses, add ipratropium bromide 500 mcg to the beta-agonist 1
- Continuous nebulization (10-15 mg/hour) may be more effective than intermittent dosing in severe cases 1
- Must be combined with oxygen and systemic corticosteroids 1
COPD Exacerbations
- Nebulized albuterol 2.5-5 mg or terbutaline 5-10 mg every 4-6 hours 1
- For severe COPD exacerbations, adding ipratropium bromide to beta-agonists has not shown additional benefit (unlike in asthma) 1
- Use air-driven nebulizers (not oxygen) if CO2 retention is present to avoid worsening hypercapnia 1
Proper Inhalation Technique
MDI with Spacer
- Actuate during slow, deep inhalation (3-5 seconds) 1
- Hold breath for 10 seconds after inhalation 1
- Use valved holding chamber (spacer) with face mask for children <4 years 1
- Mouth washing and spitting after use reduces systemic absorption 1
Nebulizer
- Fill chamber with 2-5 ml total volume (dilute with 0.9% saline if needed to reach 4 ml minimum) 1
- Continue nebulization until approximately 1 minute after "spluttering" occurs (typically 5-10 minutes) 1
- Tap nebulizer cup toward end of treatment 1
- Use mouthpiece rather than face mask when possible to avoid nasal deposition, though breathless patients may prefer mask 1
Frequency and Duration Adjustments
After Initial Treatment
- If good response: Continue every 4-6 hours until peak flow >75% predicted and diurnal variability <25% 1
- If poor response: Repeat nebulized treatment within minutes or use continuous nebulization 1
- Lack of response to repeated treatments indicates need for escalation (hospital admission, possible ventilatory support) 1
Transition to Maintenance
- Switch from nebulizer to hand-held inhaler once condition stabilizes, as this permits earlier hospital discharge 1
- Observe patients for 24-48 hours after switching to MDI before discharge 1
Critical Safety Considerations
Oxygen Administration
- Always provide supplemental oxygen with nebulizer treatments in acute severe asthma 1
- Nebulizers require 6-8 L/min flow rate 1
- Beta-agonists may initially worsen oxygen saturation due to ventilation-perfusion mismatch 1
Special Populations
- Elderly patients: First treatment should be supervised as beta-agonists may rarely precipitate angina 1
- Glaucoma risk: Use mouthpiece rather than face mask with ipratropium to avoid ocular complications 1
- Pregnant women: Maintain oxygen saturation >95% 1
Common Pitfalls to Avoid
- Do not use SABA as monotherapy for long-term asthma control - regular daily use is not recommended 1
- Do not stop inhalation at the moment of actuation - this is a common error that reduces drug delivery 1
- Do not use intravenous beta-agonists routinely - they offer no advantage over inhaled therapy and cause more systemic side effects 1
- Increasing SABA use (>2 days/week for symptom relief) indicates inadequate disease control and need for intensified anti-inflammatory therapy 1